Tag: Topical
Patient Education and Novel Topical Therapies for AD Dermatology Times Source link
Eczema is a chronic condition marked by itchy, inflamed skin, and affects millions of children and adults, Topical steroids are the most commonly recommended treatment for eczema and psoriasis, but using them for too long is linked to serious skin withdrawal side effects, which can be worse than the original symptoms. Dr. Marvin Rapaport, a […]
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several positive studies in hand, including a recent phase 3 trial pitting the candidate against the current standard-of-care, Leo says its delgocitinib has growth driver potential. Now, the drugmaker […]
Topical phosphodiesterase (PF) 4 inhibitor-07038124 treatment of atopic dermatitis (AD) and plaque psoriasis is both efficacious and well-tolerated among patients, according to recent findings.1 The findings were the result of new research conducted to expand upon existing topical medication options for patients with mild-to-moderate AD or psoriasis, especially given the negative systemic adverse events often […]